Optimising infliximab induction dosing for patients with ulcerative colitis.
Erwin DreesenRuben FaelensGert Van AsscheMarc FerranteSéverine VermeireAnn GilsThomas BouillonPublished in: British journal of clinical pharmacology (2019)
TDM-based dose individualisation targeting CAUCendoscopy has the potential to improve the effectiveness of infliximab during induction therapy.